| Trial ID: | L4802 |
| Source ID: | NCT01507038
|
| Associated Drug: |
Yh14617
|
| Title: |
Safety and Efficacy of YH14617 in Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus
|
| Interventions: |
DRUG: YH14617|DRUG: YH14617|DRUG: YH14617|DRUG: Placebo
|
| Outcome Measures: |
Primary: Change from baseline in HbA1c at week 12, Baseline, Week 12 | Secondary: Change from baseline in body weight at week 12, Baseline, Week 12|Change from baseline in fasting plasma glucose at week 12, Baseline, Week 12|Change from baseline in 1,5-anhydroglucitol at week 12, Baseline, Week 12
|
| Sponsor/Collaborators: |
Sponsor: Yuhan Corporation | Collaborators: Peptron, Inc.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
84
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2011-12
|
| Completion Date: |
2015-02
|
| Results First Posted: |
|
| Last Update Posted: |
2015-02-18
|
| Locations: |
Yuhan, Seoul, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT01507038
|
